Controversies in the Surgical Management of Gastric Cancer

View More View Less
  • 1 Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

Although the incidence of gastric adenocarcinoma in the United States has declined steadily since the early 1900s, it remains a significant health problem. Progress has been made during the past few decades in several areas: Lymph node staging has been refined, perioperative mortality has fallen, and plausible adjuvant therapy has emerged. Currently, complete surgical resection is the mainstay of therapy because it is the only potentially curative option; however, considerable controversy remains regarding the specifics of a surgical approach. This article examines 4 major controversies in the management of gastric cancer: extent of gastric resection, role of extended lymph node dissection, value of elective splenectomy for proximal gastric lesions, and current state of adjuvant therapy. Pertinent retrospective and prospective studies are reviewed to help formulate meaningful conclusions.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Daniel G. Coit, Memorial Sloan-Kettering Cancer Center, Department of Surgery, 1275 York Avenue, New York, NY 10021. E-mail: coitd@mskcc.org
  • 1

    Jemal A, Thomas A, Murray T. Cancer statistics, 2002. CA Cancer J Clin 2002;52:2347.

  • 2

    MacDonald JS, Smalley SR, Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725730.

    • Search Google Scholar
    • Export Citation
  • 3

    Songun I, Bonenkamp JJ, Hermans J. Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer. Eur J Cancer 1996; 32A:433437.

    • Search Google Scholar
    • Export Citation
  • 4

    Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: Ten-year results of the German gastric cancer study. Ann Surg 1998;228:449461.

    • Search Google Scholar
    • Export Citation
  • 5

    McNeer G, Bowden L, Booner RJ. Elective total gastrectomy for cancer of the stomach: End results. Ann Surg 1974;180:252256.

  • 6

    Paolini A, Tosato F, Cassese M. Total gastrectomy in the treatment of adenocarcinoma of the cardia: Review of the results in 73 resected patients. Am J Surg 1986;151:238243.

    • Search Google Scholar
    • Export Citation
  • 7

    Butler JA, Dubrow TJ, Trezona T. Total gastrectomy in the treatment of advanced gastric cancer. Am J Surg 1989;158:602604.

  • 8

    Bozzetti F. Total versus subtotal gastrectomy in cancer of the distal stomach: Facts and fantasy. Eur J Surg Oncol 1992; 18:572579.

  • 9

    Gouzi JL, Huguier M, Fagniez PL. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: A French prospective controlled study. Ann Surg 1989; 209:162166.

    • Search Google Scholar
    • Export Citation
  • 10

    Robertson CS, Chung SC, Woods SD. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220:176182.

    • Search Google Scholar
    • Export Citation
  • 11

    Bozzetti F, Marubini E, Bonfanti G. Subtotal versus total gastrectomy for gastric cancer: Five-year survival rates in a multicenter randomized Italian trial. Ann Surg 1999; 230:170178.

    • Search Google Scholar
    • Export Citation
  • 12

    Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal-only approach: Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg 1997;225:678683.

    • Search Google Scholar
    • Export Citation
  • 13

    Ohno S, Tomisaki S, Oiwa H. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 1995;180:577582.

    • Search Google Scholar
    • Export Citation
  • 14

    Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery 1998; 123:127130.

  • 15

    Fisher B, Anderson S, Redmond CK. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:14561461.

    • Search Google Scholar
    • Export Citation
  • 16

    Pisters PW, Harrison LB, Leung DH. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859868.

    • Search Google Scholar
    • Export Citation
  • 17

    Wangensteen O, Wangensteen S, Dennis C. History of gastric surgery: Glimpses into its early and more recent past. In: Nyhus L, Wastell C, eds. Surgery of the Stomach and Duodenum. Boston, MA: Little Brown; 1986:8.

    • Search Google Scholar
    • Export Citation
  • 18

    McNeer G, Sunderland D, Ortega L. A more thorough operation for gastric cancer: Anatomical basis and description of technique. Cancer 1951;4:957967.

    • Search Google Scholar
    • Export Citation
  • 19

    Sunderland D, McNeer G, Ortega L. The lymphatic spread of gastric cancer. Cancer 1953;6:987996.

  • 20

    Kodama M, Ishikawa K, Koyama H. Study on the lymphatic flow of the lower gastric region for radical lymphadenectomy in advanced lower gastric cancer. J Jpn Surg Soc 1988;89:10081013.

    • Search Google Scholar
    • Export Citation
  • 21

    Yoshida K, Ohta K, Ohhashi I. Studies on gastric lymphatics by using activated carbon particle (CH44) and lymph node metastasis of gastric cancer. J Jpn Surg Soc 1988; 89:664670.

    • Search Google Scholar
    • Export Citation
  • 22

    Kodama Y, Sugimachi K, Soejima K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J Surg 1981;5:241248.

  • 23

    Maruyama K, Sasako M, Kinoshita T. Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer 1998;34:14801489.

  • 24

    Onate-Ocana LF, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210217.

    • Search Google Scholar
    • Export Citation
  • 25

    Degiuli M, Sasako M, Ponzetto A. Extended lymph node dissection for gastric cancer: Results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol 1997;23:310314.

    • Search Google Scholar
    • Export Citation
  • 26

    Yildirim E, Celen O, Berberoglu U. The Turkish experience with curative gastrectomies for gastric carcinoma: Is D2 dissection worthwhile? J Am Coll Surg 2001;192:2537.

    • Search Google Scholar
    • Export Citation
  • 27

    Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph node staging in gastric cancer: Is location more important than number? An analysis of 1,038 patients. Ann Surg 2000;232:362371.

    • Search Google Scholar
    • Export Citation
  • 28

    Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988;75:110112.

  • 29

    Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908914.

  • 30

    Bonenkamp JJ, van de Velde CJ, Sasako M, Hermans J. R2 compared with R1 resection for gastric cancer: Morbidity and mortality in a prospective, randomised trial. Eur J Surg 1992;158:413418.

    • Search Google Scholar
    • Export Citation
  • 31

    Cuschieri A, Weeden S, Fielding J. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC Randomized Surgical Trial. Br J Cancer 1999;79:15221530.

    • Search Google Scholar
    • Export Citation
  • 32

    Cuschieri A, Fayers P, Fielding J. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. Lancet 1996;347:995999.

    • Search Google Scholar
    • Export Citation
  • 33

    Maruyama K. Lymphatic flow of gastric cardia: A study by endoscopic lymphography [abstract]. Stomach Intest 1978;13:1533.

  • 34

    Kwon SJ. Prognostic impact of splenectomy on gastric cancer: Results of the Korean Gastric Cancer Study Group. World J Surg 1997;21:837844.

    • Search Google Scholar
    • Export Citation
  • 35

    Sugimachi K, Kodama Y, Kumashiro R. Critical evaluation of prophylactic splenectomy in total gastrectomy for the stomach cancer. Gann 1980;71:704709.

    • Search Google Scholar
    • Export Citation
  • 36

    Sakaguchi T, Sawada H, Yamada Y. Indication of splenectomy for gastric carcinoma involving the proximal part of the stomach. Hepatogastroenterology 2001;48:603605.

    • Search Google Scholar
    • Export Citation
  • 37

    Kajitani T. The general rules for the gastric cancer study in surgery and pathology. I. Clinical classification. Jpn J Surg 1981;11:127139.

    • Search Google Scholar
    • Export Citation
  • 38

    Soga J, Kobayashi K, Saito J. The role of lymphadenectomy in curative surgery for gastric cancer. World J Surg 1979;3:701708.

  • 39

    Otsuji E, Yamaguchi T, Sawai K. End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma. Surgery 1996;120:4044.

    • Search Google Scholar
    • Export Citation
  • 40

    Brady MS, Rogatko A, Dent LL, Shiu MH. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 1991;126:359364.

    • Search Google Scholar
    • Export Citation
  • 41

    Wanebo HJ, Kennedy BJ, Winchester DP. Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on long-term survival. J Am Coll Surg 1997;185:177184.

    • Search Google Scholar
    • Export Citation
  • 42

    Bonenkamp JJ, Songun I, Hermans J. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745748.

    • Search Google Scholar
    • Export Citation
  • 43

    Toge T, Hamamoto S, Itagaki E. Analysis of suppressor cell activity in spleen cells from gastric cancer patients and the effect of splenectomy on prognosis of gastric cancer. J Jpn Surg Soc 1983;84:961.

    • Search Google Scholar
    • Export Citation
  • 44

    Csendes A, Burdiles P, Rojas J. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002;131:401407.

    • Search Google Scholar
    • Export Citation
  • 45

    Estape J, Grau JJ, Lcobendas F. Mitomycin C as an adjuvant treatment to resected gastric cancer: A 10-year follow-up. Ann Surg 1991;213:219221.

    • Search Google Scholar
    • Export Citation
  • 46

    Nakajima T, Nashimoto A, Kitamura M. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomised trial. Lancet 1999;354:273277.

    • Search Google Scholar
    • Export Citation
  • 47

    Kim JP, Kwon OJ, Oh ST, Yang HK. Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992;216: 269278.

    • Search Google Scholar
    • Export Citation
  • 48

    The Gastrointestinal Tumor Study Group. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. Cancer 1982;49:11161122.

    • Search Google Scholar
    • Export Citation
  • 49

    Engstrom PF, Lavin PT, Douglass HO Jr, Brunner KW. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Cancer 1985;55: 18681873.

    • Search Google Scholar
    • Export Citation
  • 50

    The Italian Gastrointestinal Tumor Study Group. Adjuvant treatments following curative resection for gastric cancer. Br J Surg 1988;75:11001104.

    • Search Google Scholar
    • Export Citation
  • 51

    Coombes RC, Schein PS, Chilvers CE. A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. Int J Clin Oncol 1990;8:13621369.

    • Search Google Scholar
    • Export Citation
  • 52

    Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up. Lancet 1994;343:13091312.

    • Search Google Scholar
    • Export Citation
  • 53

    Weber SM, Karpeh MS. Randomized clinical trials in gastric cancer. Surg Oncol Clin North Am 2002;11:111131.

  • 54

    Allum WH, Hallissey MT, Ward LC, Hockey MS. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report. Br J Cancer 1989;60:739744.

    • Search Google Scholar
    • Export Citation
  • 55

    Kelsen DP, Schwartz G, Janjan N, Minsky B. A randomized phase II comparison of two cisplatin-paclitaxel containing chemoradiation regimens in resected gastric cancers. Radiation Therapy Oncology Group 2001, RTOG G-0114:133.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 1 0 0
Full Text Views 58 26 0
PDF Downloads 28 11 0
EPUB Downloads 0 0 0